Cytokinetics (CYTK)
45.41 -0.59 (-1.28%) 09:47 ET [NASDAQ]
45.45 x 200 46.09 x 200
Realtime by (Cboe BZX)
45.45 x 200 46.09 x 200
Realtime 45.50 -0.50 (-1.09%) 06:50 ET
for Mon, Mar 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | CYTK | AMGN | GILD | BMY | VRTX |
| Company | Cytokinetics | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 46.27 | 308.84 | 115.02 | 59.63 | 478.07 |
| High | 46.27 | 311.65 | 116.13 | 59.67 | 485.70 |
| Low | 45.13 | 308.84 | 114.85 | 59.05 | 478.07 |
| Last | 45.28 | 311.24 | 116.25 | 59.39 | 484.22 |
| Change | -0.72 | +3.18 | +1.94 | -0.23 | +4.43 |
| % Change | -1.57% | +1.03% | +1.70% | -0.39% | +0.92% |
| Volume | 7,187 | 16,332 | 95,025 | 274,090 | 8,234 |
| 20-Day Average Volume | 1,919,244 | 3,141,547 | 8,002,016 | 12,081,220 | 1,373,307 |
| Previous Close | 46.00 | 308.06 | 114.31 | 59.62 | 479.79 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.23 | 299.83 | 105.17 | 57.13 | 473.55 |
| 20-Day Raw Stochastic | 45.85% | 79.81% | 99.95% | 81.96% | 86.67% |
| 20-Day Relative Strength | 46.73% | 63.28% | 76.95% | 56.35% | 61.33% |
| Weighted Alpha | -31.08 | +12.31 | +70.76 | +17.94 | +16.34 |
| Today's Opinion | 96% Sell | 24% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 96% Sell | 24% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 64% Sell | 56% Sell | 100% Buy | 88% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.13% since 02/24/25 | +0.50% since 02/24/25 | +4.58% since 02/24/25 | +2.16% since 02/24/25 | +0.84% since 02/24/25 |
| Low | 42.87 on 02/28/25 | 303.10 on 02/27/25 | 108.40 on 02/26/25 | 56.96 on 02/27/25 | 473.51 on 02/27/25 |
| High | 48.67 on 02/25/25 | 318.30 on 02/25/25 | 116.13 on 03/03/25 | 59.94 on 02/25/25 | 486.14 on 02/25/25 |
| 1-Month | |||||
| %Chg | -5.77% since 02/03/25 | +7.75% since 02/03/25 | +18.03% since 02/03/25 | -1.37% since 02/03/25 | +3.26% since 02/03/25 |
| Low | 40.53 on 02/12/25 | 284.52 on 02/04/25 | 94.56 on 02/10/25 | 53.54 on 02/18/25 | 446.00 on 02/12/25 |
| High | 51.74 on 02/21/25 | 318.30 on 02/25/25 | 116.13 on 03/03/25 | 60.36 on 02/05/25 | 491.80 on 02/05/25 |
| 3-Month | |||||
| %Chg | -11.34% since 12/03/24 | +11.83% since 12/03/24 | +25.55% since 12/03/24 | +0.75% since 12/03/24 | +6.29% since 12/03/24 |
| Low | 40.53 on 02/12/25 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 53.54 on 02/18/25 | 377.85 on 12/19/24 |
| High | 52.80 on 01/27/25 | 318.30 on 02/25/25 | 116.13 on 03/03/25 | 61.10 on 01/27/25 | 491.80 on 02/05/25 |
| 6-Month | |||||
| %Chg | -16.29% since 09/03/24 | -5.83% since 09/03/24 | +45.70% since 09/03/24 | +17.04% since 09/03/24 | +2.10% since 09/03/24 |
| Low | 40.53 on 02/12/25 | 253.30 on 12/19/24 | 77.74 on 09/05/24 | 47.55 on 09/09/24 | 377.85 on 12/19/24 |
| High | 59.39 on 11/11/24 | 339.17 on 09/23/24 | 116.13 on 03/03/25 | 61.10 on 01/27/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,428,644 | 165,491,376 | 142,460,656 | 120,987,584 | 123,205,280 |
| Shares Outstanding, K | 118,014 | 537,205 | 1,246,266 | 2,029,312 | 256,790 |
| Annual Sales | 7,530,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 | 11,020,100,000 |
| Annual Net Income | -526,240,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 | -535,600,000 |
| Last Quarter Sales | 460,000 | 9,086,000,000 | 7,569,000,000 | 12,342,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -160,550,000 | 627,000,000 | 1,783,000,000 | 72,000,000 | 913,000,000 |
| 60-Month Beta | 0.83 | 0.56 | 0.18 | 0.45 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 02/27/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 1.67 on 02/06/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 02/27/25 | 02/04/25 | 04/24/25 | 04/24/25 | 02/10/25 |
| Most Recent Dividend | N/A | 2.380 on 02/14/25 | 0.770 on 12/13/24 | 0.620 on 01/03/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 03/14/25 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.43 | 24.29 | 51.58 | 0.00 |